Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 11Sarcoma 4Gynecologic 4Genitourinary 3Gastrointestinal 3Breast 3Thoracic 2Dermatologic 2NET 1Lymphoid 1Endocrine 1CNS 1

Conditions

Glioblastoma 108Brain Neoplasms 106Glioma 83Neuroblastoma 34Astrocytoma 26Neoplasms 25Medulloblastoma 25Central Nervous System Neoplasms 25Neurofibromatosis 1 23Meningioma 23Ependymoma 22Sarcoma 21Breast Neoplasms 18Rhabdoid Tumor 16Melanoma 16Neurofibroma, Plexiform 15Carcinoma, Non-Small-Cell Lung 15Osteosarcoma 14Wilms Tumor 13Rhabdomyosarcoma 13Thyroid Neoplasms 12Sarcoma, Ewing 12Hepatoblastoma 12Gliosarcoma 12Recurrence 11Diffuse Intrinsic Pontine Glioma 11Pheochromocytoma 10Pancreatic Neoplasms 10Neoplasm Metastasis 10Ovarian Neoplasms 9

Interventions

entrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × CNS × 30 days × Clear all
NCT02568267 2026-05-27

STARTRK-2

Hoffmann-La Roche

Phase 2 Active not recruiting
534 enrolled 1 FDA
BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidNETSarcomaThoracic

Thyroid Cancer, Papillary, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Colorectal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Cholangiocarcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡